$0.38
9.89% today
Nasdaq, Apr 04, 09:16 pm CET
ISIN
US2826442020
Symbol
EKSO

Ekso Bionics Holdings, Inc. Stock price

$0.42
-0.06 13.15% 1M
-0.60 58.95% 6M
-0.19 31.36% YTD
-1.02 70.92% 1Y
-2.35 84.88% 3Y
-2.13 83.58% 5Y
-219.03 99.81% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
+0.00 0.89%
ISIN
US2826442020
Symbol
EKSO
Sector

Key metrics

Market capitalization $10.39m
Enterprise Value $9.88m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.55
P/S ratio (TTM) P/S ratio 0.58
P/B ratio (TTM) P/B ratio 0.73
Revenue growth (TTM) Revenue growth -1.94%
Revenue (TTM) Revenue $17.93m
EBIT (operating result TTM) EBIT $-10.46m
Free Cash Flow (TTM) Free Cash Flow $-9.88m
Cash position $6.49m
EPS (TTM) EPS $-0.57
P/E forward negative
P/S forward 0.47
EV/Sales forward 0.45
Short interest 3.18%
Show more

Is Ekso Bionics Holdings, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Ekso Bionics Holdings, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Ekso Bionics Holdings, Inc. forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Ekso Bionics Holdings, Inc. forecast:

Buy
100%

Financial data from Ekso Bionics Holdings, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
18 18
2% 2%
100%
- Direct Costs 8.41 8.41
9% 9%
47%
9.51 9.51
5% 5%
53%
- Selling and Administrative Expenses 14 14
17% 17%
81%
- Research and Development Expense 3.87 3.87
23% 23%
22%
-8.85 -8.85
34% 34%
-49%
- Depreciation and Amortization 1.61 1.61
5% 5%
9%
EBIT (Operating Income) EBIT -10 -10
31% 31%
-58%
Net Profit -11 -11
25% 25%
-63%

In millions USD.

Don't miss a Thing! We will send you all news about Ekso Bionics Holdings, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Ekso Bionics Holdings, Inc. Stock News

Neutral
Seeking Alpha
about one month ago
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Company Participants Stephen Kilmer - IR Jerome Wong - Chief Financial Officer Scott Davis - Chief Executive Officer Conference Call Participants Li Chen - H.C. Wainwright Ben Haynor - Lake Street Capital Operator Greetings, and welcome to the Ekso Bionics Fourth Quarter 2024 Financial Results C...
Neutral
GlobeNewsWire
about one month ago
SAN RAFAEL, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and twelve months ended December 31, 2024.
Neutral
GlobeNewsWire
about one month ago
SAN RAFAEL, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2024 after the close of trading on Monday, March 3, 2025. Management will host a conference call begi...
More Ekso Bionics Holdings, Inc. News

Company Profile

Ekso Bionics Holdings, Inc. engages in the design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following business segments: EksoHealth, EksoWorks, and Other. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in Richmond, CA.

Head office United States
CEO Scott Davis
Employees 61
Founded 2012
Website www.eksobionics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today